From discovery to market
We provide full-service Imaging Diagnostics Clinical Development, from pre-clinical to IND and NDA submission and Medical Affairs.
We have developed current market leaders
We have led 9 new drug approvals globally: MRI, CT, and radiopharmaceuticals.
Literature-based approvals
Utilizing only existing literature reviews, we have gained 5 new indications for imaging drugs without performing additional clinical trials.
Over 40 years of experience
Between our two RadMD principals, there are over 40 years of contrast agent development experience.
Regulatory Experience:
- Submitted NDAs for contrast agents and radiopharmaceuticals in multiple countries
- Clinical lead for regulatory discussions globally
- Contributed to development guidelines for FDA and EMA
Imaging management solutions
Our full-service imaging management solutions provide a comprehensive set of services to support pharmaceutical, medical device, and AI companies with their clinical trials.
Our reader group
We are the global leader in providing consultants to perform imaging BICR (blinded independent central reviews)
Oncology
A radiologist-led imaging provider focusing on blinded central and site reads with a specialty in oncology trials
AI validation
RadMD is the global leader providing expert readers, truthers, and core lab operations to perform blinded imaging and clinical reviews to meet the rigorous needs of AI imaging trials